Researchers discuss the history of endocrine therapies, highlights their adverse metabolic effects, and emphasizes the need for better biomarkers of diabetes.
Investments in Studying Solid Tumors Could Increase in 2024 | Psychedelic Invest
What does this mean for the psychedelic industry? In the ever-evolving landscape of biopharmaceutical investments, a notable shift is occurring, drawing eyes toward neuroscience and